Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.48
+0.02 (0.11%)
Aug 17, 2026, 4:00 PM EDT - Market closed
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.63 billion as of August 18, 2026. Its market cap has increased by 187.52% in one year.
Market Cap
2.63B
Enterprise Value
2.31B
1-Year Change
187.52%
Ranking
Category
Stock Price
$18.48
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.63B, an increase of 2,997.99%. That is a compound annual growth rate of 60.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.63B | 64.00% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.82B |
| Beam Therapeutics | 2.69B |
| AtaiBeckley | 2.69B |
| Kodiak Sciences | 2.65B |
| Ultragenyx Pharmaceutical | 2.56B |
| Hemab Therapeutics Holdings | 2.55B |
| Viridian Therapeutics | 2.54B |
| SELLAS Life Sciences Group | 2.51B |